Last reviewed · How we verify
Voclosporin High Dose
Voclosporin High Dose is a Small molecule drug developed by Aurinia Pharmaceuticals Inc.. It is currently in Phase 2 development. Also known as: ISA247.
At a glance
| Generic name | Voclosporin High Dose |
|---|---|
| Also known as | ISA247 |
| Sponsor | Aurinia Pharmaceuticals Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV) (PHASE2)
- Study of ISA247 (Voclosporin) in De Novo Renal Transplantation (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Voclosporin High Dose CI brief — competitive landscape report
- Voclosporin High Dose updates RSS · CI watch RSS
- Aurinia Pharmaceuticals Inc. portfolio CI
Frequently asked questions about Voclosporin High Dose
What is Voclosporin High Dose?
Voclosporin High Dose is a Small molecule drug developed by Aurinia Pharmaceuticals Inc..
Who makes Voclosporin High Dose?
Voclosporin High Dose is developed by Aurinia Pharmaceuticals Inc. (see full Aurinia Pharmaceuticals Inc. pipeline at /company/aurinia-pharmaceuticals-inc).
Is Voclosporin High Dose also known as anything else?
Voclosporin High Dose is also known as ISA247.
What development phase is Voclosporin High Dose in?
Voclosporin High Dose is in Phase 2.
Related
- Manufacturer: Aurinia Pharmaceuticals Inc. — full pipeline
- Also known as: ISA247
- Compare: Voclosporin High Dose vs similar drugs
- Pricing: Voclosporin High Dose cost, discount & access